D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CAH holding history
Cardinal Health Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CAH overviewAll 13F holders of CAHFull Q2 2026 holdings
- Shares (Q2 2026)
- 550,261
- Value
- $130.7M
- % of portfolio
- 0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 550,261 | $130.7M | 0.1% | +185,091+50.7% | Added | Holders |
| Q1 2026 | 365,170 | $77.2M | 0.1% | −124,467−25.4% | Reduced | Holders |
| Q4 2025 | 489,637 | $100.6M | 0.1% | −122,414−20.0% | Reduced | Holders |
| Q3 2025 | 612,051 | $96.1M | 0.1% | −244,228−28.5% | Reduced | Holders |
| Q2 2025 | 856,279 | $143.9M | 0.1% | −413,922−32.6% | Reduced | Holders |
| Q1 2025 | 1,270,201 | $175.0M | 0.2% | +248,790+24.4% | Added | Holders |
| Q4 2024 | 1,021,411 | $120.8M | 0.1% | +119,097+13.2% | Added | Holders |
| Q3 2024 | 902,314 | $99.7M | 0.1% | +588,388+187.4% | Added | Holders |
| Q2 2024 | 313,926 | $30.9M | <0.1% | +102,166+48.2% | Added | Holders |
| Q1 2024 | 211,760 | $23.7M | <0.1% | −669−0.3% | Reduced | Holders |
| Q4 2023 | 212,429 | $21.4M | <0.1% | +212,429 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −30,910−100.0% | Sold out | Holders |
| Q2 2023 | 30,910 | $2.92M | <0.1% | +15,607+102.0% | Added | Holders |
| Q1 2023 | 15,303 | $1.16M | <0.1% | −824−5.1% | Reduced | Holders |
| Q4 2022 | 16,127 | $1.24M | <0.1% | −101,606−86.3% | Reduced | Holders |
| Q3 2022 | 117,733 | $7.85M | <0.1% | −140,084−54.3% | Reduced | Holders |
| Q2 2022 | 257,817 | $13.5M | <0.1% | −291,573−53.1% | Reduced | Holders |
| Q1 2022 | 549,390 | $31.1M | <0.1% | −1,393,854−71.7% | Reduced | Holders |
| Q4 2021 | 1,943,244 | $100.1M | 0.1% | −605,576−23.8% | Reduced | Holders |
| Q3 2021 | 2,548,820 | $126.1M | 0.2% | −295,273−10.4% | Reduced | Holders |
| Q2 2021 | 2,844,093 | $162.4M | 0.2% | −34,122−1.2% | Reduced | Holders |
| Q1 2021 | 2,878,215 | $174.9M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.